Relationship between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 3, 2006, Pages

  Charkoudian, N ^a,b   Joyner, M J ^a,b   Barnes, S A ^a,b   Johnson, C P ^b   Eisenach, J H ^b   Dietz, N M ^b   Wallin, B G ^c  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cardiac output; Hypertension; Sympathetic nervous system

Indexed keywords

ACETYLENE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG INHIBITION; HEART OUTPUT; HEMODYNAMICS; HUMAN; MALE; MUSCLE INNERVATION; NERVE CONDUCTION; NEUROGRAPHY; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYSTEMIC CIRCULATION; VASODILATATION;

ADULT; BLOOD PRESSURE; CARBON DIOXIDE; CARDIAC OUTPUT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE; VASODILATION;

EID: 33748424136     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00234.2006     Document Type: Article

References (20)

1. Casino PR, Kilcoyne CM, Cannon RO III, Quyyumi AA, and Panza JA. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 75: 40-44, 1995.
2. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, and Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88: 2541-2547, 1993.
3. Charkoudian N, Joyner MJ, Johnson CP, Eisenach JH, Dietz NM, and Wallin BG. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 568: 315-321, 2005.
4. Charkoudian N, Joyner MJ, Sokolnicki LA, Johnson CP, Eisenach JH, Dietz NM, Curry TB, and Wallin BG. Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572: 821-827, 2006.
5. Cui J, Zhang R, Wilson TE, Witkowski S, Crandall CG, and Levine BD. Nitric oxide synthase inhibition does not affect regulation of muscle sympathetic nerve activity during head-up tilt. Am J Physiol Heart Circ Physiol 285: H2105-H2110, 2003.
6. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO, and Joyner MJ. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol 480: 361-368, 1994.
7. Dinenno FA and Joyner MJ. Combined NO and PG inhibition augments alpha-adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol 287: H2576-H2584, 2004.
8. Durand S, Davis SL, Cui J, and Crandall CG. Exogenous nitric oxide inhibits sympathetically mediated vasoconstriction in human skin. J Physiol 562: 629-634, 2005.
9. Halliwill JR, Minson CT, and Joyner MJ. Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans. J Appl Physiol 89: 1830-1836, 2000.
10. Hansen J, Jacobsen TN, and Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension 24: 439-444, 1994.
11. Johnson BD, Beck KC, Proctor DN, Miller J, Dietz NM, and Joyner MJ. Cardiac output during exercise by the open circuit acetylene washin method: comparison with direct Fick. J Appl Physiol 88: 1650-1658, 2000.
12. Joyner MJ and Dietz NM. Nitric oxide and vasodilation in human limbs. J Appl Physiol 83: 1785-1796, 1997.
13. Mayer BX, Mensik C, Krishnaswami S, Derendorf H, Eichler HG, Schmetterer L, and Wolzt M. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans. Br J Clin Pharmacol 47: 539-544, 1999.
14. Skarphedinsson JO, Elam M, Jungersten L, and Wallin BG. Sympathetic nerve traffic correlates with the release of nitric oxide in humans: implications for blood pressure control. J Physiol 501: 671-675, 1997.
15. Sundlöf G and Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 274: 621-637, 1978.
16. Sundlöf G and Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 272: 383-397, 1977.
17. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, Sudano I, and Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91: 1981-1987, 1995.
18. Wallin BG, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, and Jennings G. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 453: 45-58, 1992.
19. Wallin BG, Thompson JM, Jennings GL, and Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 491: 881-887, 1996.
20. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 43: 639-649, 1999.